National Institute on Drug Abuse; Notice of Webinar Meeting, 28528-28529 [2014-11253]

Download as PDF 28528 Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices EMCDONALD on DSK67QTVN1PROD with NOTICES amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel. NIDDK R13 Conference Grant Applications Date: June 17, 2014. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Jian Yang, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7799, yangj@ extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Novel Methods for Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological Diseases (U01). Date: June 23–24, 2014. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: Residence Inn, Marriott, 7335 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Najma Begum, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 749, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8894, begumn@niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, PAR–14–064: Research Using Subjects from Selected Type 1 Diabetes Clinical Studies (DP3). Date: July 2, 2014. Time: 2:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–7682, campd@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, U54 Urology Research Center Applications. Date: July 14–15, 2014. VerDate Mar<15>2010 20:00 May 15, 2014 Jkt 232001 Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jian Yang, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 755, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7799, yangj@ extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: May 12, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–11250 Filed 5–15–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel NIDCR Secondary Data Analysis R03 review. Date: June 17, 2014. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Jayalakshmi Raman, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Dental and Craniofacial Research, One Democracy Plaza, Room 670, Bethesda, MD 20892–4878, 301– 594–2904, ramanj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Disorders Research, National Institutes of Health, HHS) Dated: May 12, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–11247 Filed 5–15–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Webinar Meeting Pursuant to the NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)), notice is hereby given that the National Institute on Drug Abuse (NIDA) will host a meeting to enable public discussion on the Institute’s proposal to reorganize its extramural program in establishment of a Division of Extramural Research. DATES: This public meeting will take place on May 30, 2014 at 2 p.m., with attendance limited to space available. ADDRESSES: Webex Meeting via: https://nida-events.webex.com/nidaevents/onstage/ g.php?d=660244762&t=a. Participants are encouraged to join this meeting at the link provided at least 20 minutes prior to the scheduled start time. Instructions for joining the event can be found below: 1. Enter the Web url above into your web browser address bar and hit enter. 2. If requested, enter your name and email address. 3. If a password is required, enter the meeting password: Friday5! 4. Click ‘‘Join.’’ For audio support to this event, the audio conference information is as follows: Phone Number: 1–866–842–0779. Participant Code No. 4459104. Any interested person may file written comments by sending an email to NIDADERComment@mail.nih.gov, by June 3, 2014. The statement should include the individual’s name, contact information and, when applicable, professional affiliation. FOR FURTHER INFORMATION CONTACT: Dave Daubert, Deputy Executive Officer, National Institute on Drug Abuse, Office of Management, 6001 Executive Boulevard, NSC Building, Room 5274, Bethesda, MD 20892, 301–402–1652, daubert@nih.gov. SUPPLEMENTARY INFORMATION: The agenda for this meeting will consist of updates made to the proposed SUMMARY: E:\FR\FM\16MYN1.SGM 16MYN1 Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices reorganization plans for the NIDA extramural program in establishment of a Division of Extramural Research based on initial discussions, public comment and feedback at the NIDA Advisory Council on Drug Abuse Meeting on May 7th. The proposal seeks to clearly delineate functions and streamline the services provided within the Office of the Director, as well as capitalize on emerging scientific opportunities, while reducing barriers to scientific and interdisciplinary collaboration. Members of the public wishing to attend must view the discussion via webex link https://nidaevents.webex.com/nida-events/onstage/ g.php?d=660244762&t=a and enter the audio conference information above from their telephone. Upon opening the link provided, please contact your IT support group for assistance in uploading any necessary drivers (e.g. MBR2 player) prior to the start of this event. Dated: May 8, 2014. Nora Volkow, Director, National Institute on Drug Abuse, National Institutes of Health. [FR Doc. 2014–11253 Filed 5–15–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health EMCDONALD on DSK67QTVN1PROD with NOTICES Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee to the Director, National Institutes of Health. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Mar<15>2010 20:00 May 15, 2014 Jkt 232001 Name of Committee: Advisory Committee to the Director, National Institutes of Health. Date: June 5–6, 2014. Open: June 05, 2014, 9:00 a.m. to 4:15 p.m. Agenda: NIH Director’s Report, NIH Updates, and other business of the committee. Place: National Institutes of Health, Building 1, Room 126, 1 Center Drive, Bethesda, MD 20892. Closed: June 05, 2014, 4:15 p.m. to 5:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 1, Room 126, 1 Center Drive, Bethesda, MD 20892. Open: June 06, 2014, 9:00 a.m. to 12:00 p.m. Agenda: ACD Working Group reports, NIH updates, and other business of the committee. Place: National Institutes of Health, Building 1, Room 126, 1 Center Drive, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 103, Bethesda, MD 20892, 301–496–4272, woodgs@od.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// acd.od.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: May 12, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–11251 Filed 5–15–14; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 28529 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group Kidney, Urologic and Hematologic Diseases D Subcommittee. Date: June 18–19, 2014. Open: June 18, 2014, 8:00 a.m. to 8:30 a.m. Agenda: To review policy and procedures. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: June 18, 2014, 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: June 19, 2014, 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Barbara A. Woynarowska, Ph.D., Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 754, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 402–7172, woynarowskab@ niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group Diabetes, Endocrinology and Metabolic Diseases B Subcommittee. Date: June 18–20, 2014. Open: June 18, 2014, 3:00 p.m. to 3:30 p.m. Agenda: To review policy and procedures. Place: The Palmer House Hilton, 17 East Monroe Street, Chicago, IL 60603. E:\FR\FM\16MYN1.SGM 16MYN1

Agencies

[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Pages 28528-28529]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11253]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Webinar Meeting

SUMMARY: Pursuant to the NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)), 
notice is hereby given that the National Institute on Drug Abuse (NIDA) 
will host a meeting to enable public discussion on the Institute's 
proposal to reorganize its extramural program in establishment of a 
Division of Extramural Research.

DATES: This public meeting will take place on May 30, 2014 at 2 p.m., 
with attendance limited to space available.

ADDRESSES: Webex Meeting via: https://nida-events.webex.com/nida-events/onstage/g.php?d=660244762&t=a. Participants are encouraged to 
join this meeting at the link provided at least 20 minutes prior to the 
scheduled start time.
    Instructions for joining the event can be found below:
    1. Enter the Web url above into your web browser address bar and 
hit enter.
    2. If requested, enter your name and email address.
    3. If a password is required, enter the meeting password: Friday5!
    4. Click ``Join.''
    For audio support to this event, the audio conference information 
is as follows:
    Phone Number: 1-866-842-0779.
    Participant Code No. 4459104.
    Any interested person may file written comments by sending an email 
to NIDADERComment@mail.nih.gov, by June 3, 2014. The statement should 
include the individual's name, contact information and, when 
applicable, professional affiliation.

FOR FURTHER INFORMATION CONTACT: Dave Daubert, Deputy Executive 
Officer, National Institute on Drug Abuse, Office of Management, 6001 
Executive Boulevard, NSC Building, Room 5274, Bethesda, MD 20892, 301-
402-1652, daubert@nih.gov.

SUPPLEMENTARY INFORMATION: The agenda for this meeting will consist of 
updates made to the proposed

[[Page 28529]]

reorganization plans for the NIDA extramural program in establishment 
of a Division of Extramural Research based on initial discussions, 
public comment and feedback at the NIDA Advisory Council on Drug Abuse 
Meeting on May 7th. The proposal seeks to clearly delineate functions 
and streamline the services provided within the Office of the Director, 
as well as capitalize on emerging scientific opportunities, while 
reducing barriers to scientific and interdisciplinary collaboration.
    Members of the public wishing to attend must view the discussion 
via webex link https://nida-events.webex.com/nida-events/onstage/g.php?d=660244762&t=a and enter the audio conference information above 
from their telephone. Upon opening the link provided, please contact 
your IT support group for assistance in uploading any necessary drivers 
(e.g. MBR2 player) prior to the start of this event.

    Dated: May 8, 2014.
Nora Volkow,
Director, National Institute on Drug Abuse, National Institutes of 
Health.
[FR Doc. 2014-11253 Filed 5-15-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.